Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Respir Med ; 107(12): 2029-37, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24084061

ABSTRACT

OBJECTIVE: The Fifty-ninth Turkish Government announced an emergency action plan and embarked on a comprehensive health reform named "Health Transformation Program" (HTP) in 2003. This study investigated the effects of HTP on tuberculosis (TB) burden from 2003 to 2010 in Turkey. DESIGN: TB incidence, prevalence, mortality and case detection rates, treatment success and direct observed treatment strategy (DOTS) applications rate, and contribution of these applications in the success of the TB war were retrospectively investigated. RESULTS: The annual decrease of incidence rate was 2.86 between 1995 and 2002, and 1.22 between and 2003 and 2010, (p < 0.05). The decrease of prevalence rate was 2.88 between 1995 and 2002 and 1.25 between 2003 and 2010 (p < 0.05). The annual declines in mortality were 0.44 between 1995 and 2002 and 0.22 between 2003 and 2010 (p < 0.005). The DOTS application rate increased from 0% in 2003 to 98% in 2010. After the HTP treatment success rate of TB at 85% of Turkey was firstly reached to 89% in 2005 and increased to 91% in 2007. Case detection rate of new pulmonary TB patients was 82% in 2005 and 81% in 2008 reaching the WHO target for the first time with HTP. CONCLUSION: A trend of reduced TB burden began in Turkey in 1997. As a result of the implementation of HTP beginning in 2003, the target treatment success and DOTS application rates were achieved and progress has continued even in the face of the recent worldwide economic crisis.


Subject(s)
Tuberculosis/prevention & control , Budgets , Communicable Disease Control/organization & administration , Cost of Illness , Health Care Reform/economics , Health Care Reform/organization & administration , Humans , Incidence , Mortality/trends , Mycobacterium tuberculosis , Prevalence , Tuberculosis/epidemiology , Tuberculosis/mortality , Turkey/epidemiology
2.
Cent Eur J Public Health ; 21(2): 80-7, 2013 Jun.
Article in English | MEDLINE | ID: mdl-24053063

ABSTRACT

Child survival is the focus of the fourth Millenium Developmental Goal (MDG4). This paper describes levels, trends, and differentials in Under-Five Mortality Rate (U5MR) and also summarizes state programmes in Turkey between 1988 and 2010. Turkey is among only a few countries that have already surpassed MDG4 and have reduced their under-five mortality rate by more than two-thirds. In 2010, 13 out of every 1,000 children died before their fifth birthday. Low birth weight, high-birth order, short birth intervals, rural residence, low level of maternal education and lowest wealth quintile have affected negatively children's chances of survival. Expanding the scope of free vaccination programmes for children, improving screening and disease prevention schemes aimed at children, encouraging breastfeeding, implementing an emergency obstetric care programme, improving the services provided to newborns (a newborn intensive care programme) have brought about a significant decrease in the rate of infant and under-five mortality. The implementation of state and region specific action plans should be necessary to increase the chance of an access to the Continuum of Care for each mother and infant and to surpass MDG4.


Subject(s)
Child Mortality/trends , Infant Mortality/trends , Maternal Health Services/organization & administration , Primary Prevention/organization & administration , Birth Order , Breast Feeding , Child, Preschool , Female , Humans , Infant , Infant, Low Birth Weight , Infant, Newborn , Male , Maternal Mortality/trends , Prenatal Care/organization & administration , Residence Characteristics/statistics & numerical data , Socioeconomic Factors , Turkey/epidemiology , Vaccination/statistics & numerical data
3.
Acta Trop ; 120(1-2): 15-23, 2011.
Article in English | MEDLINE | ID: mdl-21781952

ABSTRACT

Turkey is located in the middle of Asia, Africa and Europe, close to Caucasia, Balkans and Middle East in subtropical climate zone. Malaria has been known since the early ages of human history and it was one of the leading diseases in Anatolian history, as well. Today, chloroquine-sensitive Plasmodium vivax is the only agent of autochthonous malaria cases in Turkey. The other Plasmodium species identified are isolated from imported cases of malaria. The most common vector of malaria in Turkey is Anopheles sacharovi followed by An. superpictus, An. maculipennis and An. subalpinus. In 2009, pre-elimination stage of Malaria Program was started due to dramatic decline in the number of malaria cases in Turkey (Total, 84; 38 autochthonous cases only in 26 foci in south-eastern Anatolia, and 46 imported cases; incidence: 0.1/100,000). As there were no detected cases of new autochthonous malaria in the first 8 months of 2010, elimination stage was started. The role of the persistent policies and successful applications of the Ministry of Health, such as the strict control of the patients using anti-malarial drugs especially chloroquine, avoidance of resistant insecticides, facilitation of access to patients via Health Transformation Program (HTP), establishment of close contact with the patients' families, and improvement of reporting and surveillance system, was essential. In addition, improvement maintained in the motivations and professional rights of malaria workers, as well in the coordination of field studies and maintenance of a decline or termination in vector-to-person transmission were all achieved with the insistent policies of the Ministry of Health. Other factors that probably contributed to elimination studies include lessening of military operations in south-eastern Anatolia and the lowering of malaria cases in neighbouring countries in recent years. Free access to health services concerning malaria is still successfully conducted throughout the country.


Subject(s)
Anopheles/parasitology , Disease Outbreaks/prevention & control , Insect Vectors/parasitology , Malaria, Vivax/epidemiology , Malaria, Vivax/prevention & control , Animals , Antimalarials/pharmacology , Chloroquine/pharmacology , Humans , Malaria, Vivax/transmission , Plasmodium/isolation & purification , Travel , Turkey/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...